Ratnakar Securities Pvt. Ltd.

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark

BSE2223.05-3.6 (-0.16 %)

PREV CLOSE ( ) 2226.65

OPEN PRICE ( ) 2226.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 34680

TODAY'S LOW / HIGH ( )2195.00 2252.85

52 WK LOW / HIGH ( )1274.7 2286.15

Select year

Particulars	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Operational & Financial Ratios
Earnings Per Share (Rs)	-53.21	10.53	33.37	34.38	27.50
CEPS(Rs)	-44.26	17.00	52.46	50.10	42.28
DPS(Rs)	2.50	2.50	2.50	2.50	2.50
Book NAV/Share(Rs)	277.46	335.13	321.45	249.60	214.65
Tax Rate(%)	5116.71	137.34	31.06	29.83	29.20
Margin Ratios
Core EBITDA Margin(%)	4.31	5.79	8.35	8.26	15.96
EBIT Margin(%)	1.99	2.09	6.26	6.88	13.85
Pre Tax Margin(%)	0.13	0.85	5.18	5.48	10.30
PAT Margin (%)	-6.61	-0.32	3.57	3.84	7.29
Cash Profit Margin (%)	-4.51	1.70	5.32	5.60	11.21
Performance Ratios
ROA(%)	-11.86	-0.54	6.74	7.11	6.17
ROE(%)	-21.18	-0.97	12.33	14.81	13.32
ROCE(%)	4.88	4.43	14.19	15.30	14.04
Asset Turnover(x)	1.79	1.71	1.89	1.85	0.85
Sales/Fixed Asset(x)	2.77	2.74	2.94	2.97	1.44
Working Capital/Sales(x)	17.22	7.28	7.74	7.99	3.97
Efficiency Ratios
Fixed Capital/Sales(x)	0.36	0.36	0.34	0.34	0.70
Receivable days	36.38	43.76	37.24	36.01	78.95
Inventory Days	32.19	31.52	31.35	31.90	75.25
Payable days	190.23	186.18	191.57	219.98	218.90
Valuation Parameters
PER(x)	0.00	44.14	13.25	13.51	7.49
PCE(x)	-21.63	27.36	8.43	9.27	4.87
Price/Book(x)	3.45	1.39	1.38	1.86	0.96
Yield(%)	0.26	0.54	0.57	0.54	1.21
EV/Net Sales(x)	2.23	1.41	1.20	1.52	0.90
EV/Core EBITDA(x)	12.95	8.48	5.93	7.80	5.15
EV/EBIT(x)	47.70	27.69	8.47	9.60	6.50
EV/CE(x)	2.98	1.18	0.96	1.18	0.72
M Cap / Sales	2.29	1.13	1.01	1.20	0.55
Growth Ratio
Net Sales Growth(%)	1.98	-5.86	12.44	2.85	7.86
Core EBITDA Growth(%)	5.79	-22.64	16.51	14.91	3.55
EBIT Growth(%)	-6.18	-66.14	0.22	17.80	-9.90
PAT Growth(%)	-1944.25	-109.01	2.43	25.02	-16.11
EPS Growth(%)	-605.16	-68.44	-2.92	25.01	-16.11
Financial Stability Ratios
Total Debt/Equity(x)	0.13	0.46	0.40	0.67	0.80
Current Ratio(x)	1.28	1.85	1.77	1.75	1.65
Quick Ratio(x)	0.84	1.33	1.23	1.21	1.13
Interest Cover(x)	1.07	1.69	5.83	4.92	3.90
Total Debt/Mcap(x)	0.04	0.33	0.29	0.36	0.84

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Financial Ratios

GLENMARK PHARMACEUTICALS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES